- Home
- Press Room
Press Room
Useful Documents
In the media 2023
19 september 2023
RTBF – Octobre rose : lancement de la campagne “I miss you” pour sensibiliser à l’importance de la recherche sur le cancer du sein
19 september 2023
HLN – Kris was één van de honderd mannen per jaar die borstkanker krijgen: “Ik voelde plots knobbeltje”
19 september 2023
La Dernière Heure – Octobre rose : l’association “BIG against breast cancer” lance la campagne “I miss you”
Press Releases
2023
2022
2021
7 december 2021
First results of MA.32 trial: Common diabetes drug not effective against early-stage breast cancer, landmark trial reveals
2020
29 mei 2020
Update on PALLAS, an International Academic Breast Cancer Study Evaluating Adjuvant Palbociclib
23 januari 2020
Breast cancer prevention – significant progress: 49% reduction in breast cancer occurrence with anastrozole (long-term follow up results of the IBIS II Prevention trial)
2019
1 mei 2019
Progress in the fight against metastatic breas cancer
11 januari 2019
Belgium has the highest incidence of breast cancer in the world!
2018
2017
2016
29 juli 2016
New England Journal of Medicine” publishes results of MINDACT clinical trial The 70-gene test (Mammaprint®) can significantly reduce use of chemotherapy among breast cancer patients and has the potential to change clinical practice: 46% of early stage breast cancer patients classified as high-risk by traditional methods can avoid chemotherapy
2015
2014
10 december 2014
Opening of international PANACEA study of patients with HER2+ breast cancer
1 juni 2014
ALTTO Test of Dual HER2 Blockade Finds Single Agent – Trastuzumab – Remains the Gold Standard
1 juni 2014
New Treatment Option for Young Women with Hormone-Sensitive Breast Cancer
In the media
2023
19 september 2023
RTBF – Octobre rose : lancement de la campagne “I miss you” pour sensibiliser à l’importance de la recherche sur le cancer du sein
19 september 2023
HLN – Kris was één van de honderd mannen per jaar die borstkanker krijgen: “Ik voelde plots knobbeltje”
19 september 2023
La Dernière Heure – Octobre rose : l’association “BIG against breast cancer” lance la campagne “I miss you”
2016
6 januari 2016
Borstkanker: oncologe Martine Piccart gehuldigd | Cancer du sein: l’oncologue Martine Piccart à l’honneur (Food in Action, 6 January 2016)
15 januari 2016
Cancer du sein: interview Martine Piccart (Télé Bruxelles, 15/01/2016)
2015
27 februari 2015
The INTEGRATE project – Enabling data and knowledge sharing in biomedical research (27 Feb 2015)
26 augustus 2015
The EURECA project – Building a better healthcare future through collaboration and technology (26 August 2015)
Highlights of the EURECA Project (Enabling information re-Use by linking clinical Research and Care)
2014
15 juli 2014
How can international collaboration benefit young researchers?
2013
27 februari 2013
La princesse Mathilde plaide pour plus de recherches sur le cancer du sein (27 February 2013)
10 juni 2013
ASCO: Dr. Martine Piccart, in Karnofsky Lecture, Outlines Vision for the Empowering of Academic Research (10 June 2013) CancerNetwork, Home of the Journal Oncology
A new metastatic breast cancer programme (19 June 2013)
2009
19 september 2023
RTBF – Octobre rose : lancement de la campagne “I miss you” pour sensibiliser à l’importance de la recherche sur le cancer du sein
19 september 2023
HLN – Kris was één van de honderd mannen per jaar die borstkanker krijgen: “Ik voelde plots knobbeltje”
19 september 2023
La Dernière Heure – Octobre rose : l’association “BIG against breast cancer” lance la campagne “I miss you”
2008
Tailored treatments for breast cancer – TRANSBIG. In: Research for Europe. A selection of EU success stories, published by the EU Directorate-General for Research (2008)
For press inquiries about
- Breast International Group (BIG)
- BIG trials and research programmes
- BIG member groups
- BIG governance
- BIG press releases
Please contact:
Breast International Group (BIG) - AISBL
-
IBAN: BE08 0689 0916 0213
- Rue de Bretagne / Bretagnestraat 20 1200 Brussels, Belgium
- www.BIGagainstbc.org
- communications@BIGagainstbc.org
-
+32 24 86 16 00